Not Signed In -
Emtricitabine |
Emtriva |
Emtricitabine Systematic (IUPAC) name 4-amino-5-fluoro-1- [2-(hydroxymethyl)- 1,3-oxathiolan-5-yl]- pyrimidin-2-one Identifiers CAS number 143491-57-0 ATC code J05AF09 PubChem 60877 DrugBank APRD00226 Chemical data Formula C8H10FN3O3S Mol. weight 247.248 g/mol Pharmacokinetic data Bioavailability ? Protein binding Very low (less than 4%) Metabolism ? Half life 10 hours Excretion ? Therapeutic considerations Pregnancy cat. ? Leg ...
Wikipedia - [full article]
Emtricitabine Clinical Trials
- Emtricitabine Given Once A Day with Other Anti-HIV Drugs in Children with HIV
ClinicalTrials.gov Identifier: NCT00017992 - Recruiting
HIV Infections
- A Comparison of Emtricitabine and Stavudine Used with Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00006208 - Active, not recruiting
HIV Infections
- Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00016718 - Active, not recruiting
HIV Infections
- Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
ClinicalTrials.gov Identifier: NCT00112047 - Active, not recruiting
HIV Infections
- A 48 week study looking at the effectiveness of giving saquinavir/ritonavir, twice daily plus emtricitabine/tenofovir, once daily compared to giving lopinavir/ritonavir twice daily plus emtricitabine/tenofovir once daily in HIV-1 patients not previously t
ClinicalTrials.gov Identifier: NCT00105079 - Active, not recruiting
HIV Infections
- Efavirenz Or Atazanazir/Ritonavir Given with Emtricitabine/Tenofovir Disoproxil Fumarate Or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
ClinicalTrials.gov Identifier: NCT00118898 - Active, not recruiting
HIV Infections
- Immediate Versus Deferred Start of Anti-HIV Therapy in HIV Infected Adults Being Treated for Tuberculosis
ClinicalTrials.gov Identifier: NCT00108862 - Recruiting
HIV Infections; Tuberculosis
- Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients with Tuberculosis
ClinicalTrials.gov Identifier: NCT00115609 - Recruiting
HIV Infections; Tuberculosis
- Tenofovir DF (Disoproxil Fumarate) in Combination with Emtricitabine in HIV-1 Patients
ClinicalTrials.gov Identifier: NCT00106379 - Completed
HIV Infections
- Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
ClinicalTrials.gov Identifier: NCT00244712 - Active, not recruiting
HIV Infections
- A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine.
ClinicalTrials.gov Identifier: NCT00344461 - Recruiting
HIV
- Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
ClinicalTrials.gov Identifier: NCT00334256 - Recruiting
HIV Infection; Pregnancy
- A Study of HIV-Disease Development in Aging
ClinicalTrials.gov Identifier: NCT00006144 - Active, not recruiting
HIV Infections
- A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation
ClinicalTrials.gov Identifier: NCT00036452 - Active, not recruiting
HIV Infections
- A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
ClinicalTrials.gov Identifier: NCT00102206 - Active, not recruiting
HIV Infections
- Anti-HIV Drugs During Pregnancy
ClinicalTrials.gov Identifier: NCT00042289 - Active, not recruiting
HIV Infections
- RMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada
ClinicalTrials.gov Identifier: NCT00272779 - Active, not recruiting
HIV
- Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
ClinicalTrials.gov Identifier: NCT00458393 - Recruiting
HIV Infections
- Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
HIV Infections
- Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir DF in HIV-1-Infected Treatment Naive Adults
ClinicalTrials.gov Identifier: NCT00389207 - Recruiting
HIV Infections
- Efficacy of Tenofovir and Emtricitabine in ARV-Naive Patients With HIV/HBV co-Infection
ClinicalTrials.gov Identifier: NCT00476463 - Recruiting
Hepatitis B Virus; HIV Infections
- Efficacy and Tolerance of Peg-Interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV co-Infected Patients
ClinicalTrials.gov Identifier: NCT00391638 - Recruiting
Hepatitis B; HIV Infections
- Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
ClinicalTrials.gov Identifier: NCT00158457 - Completed
HIV Infection
- GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
ClinicalTrials.gov Identifier: NCT00362687 - Recruiting
HIV Infections
- Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease.
ClinicalTrials.gov Identifier: NCT00298363 - Recruiting
Chronic Hepatitis B
- FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment
ClinicalTrials.gov Identifier: NCT00414635 - Recruiting
HIV Infections
- Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy
ClinicalTrials.gov Identifier: NCT00120367 - Active, not recruiting
Leukoencephalopathy, Progressive Multifocal; HIV Infections
- A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes, and Eliminates a Drug), of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Nave HIV-1 Patients (
ClinicalTrials.gov Identifier: NCT00534352 - Recruiting
HIV-1 Infection
- Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
ClinicalTrials.gov Identifier: NCT00043966 - Completed
HIV Infections
- The STEAL Study
ClinicalTrials.gov Identifier: NCT00192634 - Recruiting
HIV
- Nine Month Course of Anti-HIV Medications for People Recently Infected with HIV
ClinicalTrials.gov Identifier: NCT00090779 - Recruiting
HIV Infections
- A 96 Week Study to Compare Tenofovir Versus Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00507507 - Recruiting
Chronic Hepatitis B
- NNRTI- Versus PI-Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV
ClinicalTrials.gov Identifier: NCT00089505 - Recruiting
HIV Infections
- Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women who Take Nevirapine During Pregnancy
ClinicalTrials.gov Identifier: NCT00099632 - Recruiting
HIV Infections
- A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00002362 - Suspended
HIV Infections
- Virological and Clinical Anti-HBV Efficacy of Tenofovir and Emtricitabine in Patients with HIV/HBV Co-Infection
ClinicalTrials.gov Identifier: NCT00127959 - Completed
HIV-1 infection; Hepatitis B virus infection
- Pharmacokinetics of Emtricitabine/Tenofovir + Efavirenz in HIV-Infected Patients With Tuberculosis
ClinicalTrials.gov Identifier: NCT00474435 - Not yet recruiting
Tuberculosis; HIV Infections
- Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg
ClinicalTrials.gov Identifier: NCT00476983 - Not yet recruiting
Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00524173 - Recruiting
Chronic Hepatitis B e Antigen Positive; Chronic Hepatitis B e Antigen Negative
- TMC278-TiDP6-C209: A Clinical Trial in Treatment naïve HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.
ClinicalTrials.gov Identifier: NCT00540449 - Not yet recruiting
HIV-1; HIV Infections; Human Immunodeficiency Virus Type 1
- A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects
ClinicalTrials.gov Identifier: NCT00121017 - Not yet recruiting
HIV Infection; Hepatitis C
- The Safety and Effectiveness of 524W91
ClinicalTrials.gov Identifier: NCT00002335 - Completed
HIV Infections
- Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
ClinicalTrials.gov Identifier: NCT00002416 - Completed
HIV Infections
- Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults
ClinicalTrials.gov Identifier: NCT00051831 - Suspended
HIV Infections
- Three Month Course of Anti-HIV Medications for People Recently Infected with HIV
ClinicalTrials.gov Identifier: NCT00087464 - Terminated
HIV Infections
Resources
- Emtricitabine (Drug Digest)
- Emtriva (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
